| Medical and Health Sciences | Lifetime | 499 | DE 16 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 149 | DE 7 | 99.97 |
| Biological Sciences | 2021-2025 | 574 | DE 30 | 99.39 |
| Rheumatology | Lifetime | 7 | DE 1 | 99.96 |
| Molecular Biology | Lifetime | 396 | DE 21 | 99.81 |
| Oncology | Lifetime | 304 | DE 10 | 99.50 |
| Immunology | Lifetime | 292 | DE 22 | 99.29 |
| Hematology | Lifetime | 451 | DE 36 | 97.16 |
| Orthopedics and Sports Medicine | Lifetime | 477 | DE 19 | 95.70 |
| Rheumatology | 2021-2025 | 10 | DE 3 | 99.75 |
| Oncology | 2021-2025 | 46 | DE 5 | 99.74 |
| Immunology | 2021-2025 | 33 | DE 5 | 99.27 |
| Hematology | 2021-2025 | 133 | DE 20 | 96.65 |
| Molecular Biology | 2021-2025 | 991 | DE 53 | 94.34 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 442 | DE 23 | 90.89 |
| Pathology and Forensic Medicine | 2021-2025 | 421 | DE 34 | 82.57 |
| Orthopedics and Sports Medicine | 2021-2025 | 369 | DE 20 | 70.42 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 5 | DE 1 | 99.94 |
| Bone Metabolism and Diseases | Lifetime | 5 | DE 1 | 99.91 |
| Bone and Joint Diseases | Lifetime | 5 | DE 1 | 99.89 |
| Systemic Lupus Erythematosus Research | Lifetime | 20 | DE 1 | 99.81 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 19 | DE 3 | 99.81 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 15 | DE 4 | 99.80 |
| Spondyloarthritis Studies and Treatments | Lifetime | 10 | DE 3 | 99.86 |
| Biomarkers in Disease Mechanisms | Lifetime | 10 | DE 1 | 99.07 |
| Bone health and treatments | Lifetime | 66 | DE 1 | 99.60 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 215 | DE 11 | 99.55 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 36 | DE 7 | 99.55 |
| Systemic Sclerosis and Related Diseases | Lifetime | 116 | DE 6 | 98.87 |
| Inflammasome and immune disorders | Lifetime | 107 | DE 6 | 98.64 |
| Heat shock proteins research | Lifetime | 90 | DE 12 | 98.58 |
| COVID-19 Clinical Research Studies | Lifetime | 442 | DE 16 | 98.24 |
| CAR-T cell therapy research | Lifetime | 481 | DE 33 | 98.61 |
| Long-Term Effects of COVID-19 | Lifetime | 471 | DE 18 | 96.47 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 356 | DE 15 | 98.28 |
| Immune cells in cancer | Lifetime | 565 | DE 54 | 97.08 |
| Cell Adhesion Molecules Research | Lifetime | 858 | DE 72 | 97.57 |
| Biosimilars and Bioanalytical Methods | Lifetime | 192 | DE 14 | 96.46 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 498 | DE 37 | 96.86 |
| IL-33, ST2, and ILC Pathways | Lifetime | 331 | DE 24 | 96.83 |
| Mast cells and histamine | Lifetime | 338 | DE 33 | 96.51 |
| Inflammatory mediators and NSAID effects | Lifetime | 653 | DE 29 | 96.53 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 11 | DE 1 | 93.32 |
| Vasculitis and related conditions | Lifetime | 393 | DE 26 | 96.49 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 266 | DE 10 | 96.25 |
| NF-κB Signaling Pathways | Lifetime | 467 | DE 52 | 95.94 |
| Osteomyelitis and Bone Disorders Research | Lifetime | 77 | DE 16 | 93.21 |
| Eosinophilic Disorders and Syndromes | Lifetime | 654 | DE 56 | 95.60 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 390 | DE 13 | 95.53 |
| Dermatological and Skeletal Disorders | Lifetime | 375 | DE 31 | 93.39 |
| Phagocytosis and Immune Regulation | Lifetime | 566 | DE 46 | 92.58 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 774 | DE 63 | 93.02 |
| Hematological disorders and diagnostics | Lifetime | 820 | DE 69 | 91.11 |
| Phosphodiesterase function and regulation | Lifetime | 474 | DE 53 | 88.36 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 856 | DE 25 | 88.04 |
| Dermatological and COVID-19 studies | Lifetime | 337 | DE 36 | 86.48 |
| Dupuytren's Contracture and Treatments | Lifetime | 323 | DE 31 | 84.42 |
| Connective Tissue Growth Factor Research | Lifetime | 433 | DE 36 | 83.53 |
| Skin Diseases and Diabetes | Lifetime | 769 | DE 47 | 83.04 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 4 | DE 1 | 99.81 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 12 | DE 4 | 99.70 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 18 | DE 2 | 99.31 |
| CAR-T cell therapy research | 2021-2025 | 54 | DE 4 | 99.61 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 32 | DE 1 | 99.04 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 14 | DE 3 | 99.45 |
| T-cell and B-cell Immunology | 2021-2025 | 45 | DE 4 | 98.21 |
| Viral Infectious Diseases and Gene Expression in Insects | 2021-2025 | 27 | DE 5 | 96.32 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 30 | DE 3 | 97.73 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 56 | DE 9 | 98.73 |
| Inflammasome and immune disorders | 2021-2025 | 199 | DE 6 | 92.90 |
| Virus-based gene therapy research | 2021-2025 | 496 | DE 26 | 90.09 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 763 | DE 55 | 92.67 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 170 | DE 10 | 86.73 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 519 | DE 27 | 87.46 |
| Cell Adhesion Molecules Research | 2021-2025 | 293 | DE 33 | 83.09 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 270 | DE 25 | 84.58 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 282 | DE 16 | 87.13 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 333 | DE 38 | 86.60 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 837 | DE 68 | 83.96 |
| Bone and Joint Diseases | 2021-2025 | 463 | DE 31 | 81.17 |
| Bone Metabolism and Diseases | 2021-2025 | 483 | DE 18 | 79.54 |
| Immune Response and Inflammation | 2021-2025 | 886 | DE 48 | 75.54 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 458 | DE 57 | 69.21 |
| Hematological disorders and diagnostics | 2021-2025 | 404 | DE 35 | 67.37 |
| Blood disorders and treatments | 2021-2025 | 875 | DE 76 | 60.60 |
| Skin and Cellular Biology Research | 2021-2025 | 814 | DE 89 | 52.43 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 647 | DE 98 | 50.98 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 788 | DE 55 | 47.26 |
| Alkaline Phosphatase Research Studies | 2021-2025 | 252 | DE 24 | 33.90 |
| Connective Tissue Growth Factor Research | 2021-2025 | 303 | DE 20 | 25.19 |
